These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 24319752)
1. Contra-insular effect of calcitonin on glucose metabolism. Moisa SS Bull Exp Biol Med; 2013 Dec; 156(2):217-9. PubMed ID: 24319752 [TBL] [Abstract][Full Text] [Related]
2. Calcium channel blockers inhibit the hyperglycemic effect of calcitonin. Butakova SS; Nozdrachev AD Bull Exp Biol Med; 2012 Mar; 152(5):553-9. PubMed ID: 22803131 [TBL] [Abstract][Full Text] [Related]
3. Effect of calcium-regulating hormones and calcium channel modulators on glucose consumption by muscle and adipose tissues in vivo and in vitro. Butakova SS; Nozdrachev AD Bull Exp Biol Med; 2009 Aug; 148(2):171-4. PubMed ID: 20027320 [TBL] [Abstract][Full Text] [Related]
4. Insulin secretion and carbohydrate metabolism in the dystrophic mouse. Lundquist I; Harris JB Eur J Pharmacol; 1979 Feb; 53(4):365-73. PubMed ID: 369869 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms of hyperglycemic effect of calcitonin. Butakova SS; Nozdrachev AD Bull Exp Biol Med; 2011 Jan; 150(3):320-3. PubMed ID: 21240344 [TBL] [Abstract][Full Text] [Related]
6. [Effect of calcitonin on the type of alimentary hyperglycemia in rats of different age and sex]. Butakova SS; Nozdrachev AD Adv Gerontol; 2010; 23(2):213-20. PubMed ID: 21033375 [TBL] [Abstract][Full Text] [Related]
8. Metabolic consequences of hyperinsulinaemia imposed on normal rats on glucose handling by white adipose tissue, muscles and liver. Cusin I; Terrettaz J; Rohner-Jeanrenaud F; Jeanrenaud B Biochem J; 1990 Apr; 267(1):99-103. PubMed ID: 2183797 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological studies on -guanidinobutyramide. Buckle AL; Jones HE Horm Metab Res; 1971 Mar; 3(2):76-81. PubMed ID: 4941848 [No Abstract] [Full Text] [Related]
10. Effects of pioglitazone on glucose and lipid metabolism in Wistar fatty rats. Sugiyama Y; Taketomi S; Shimura Y; Ikeda H; Fujita T Arzneimittelforschung; 1990 Mar; 40(3):263-7. PubMed ID: 2189419 [TBL] [Abstract][Full Text] [Related]
11. Regulation of glucose utilization in adipose cells and muscle after long-term experimental hyperinsulinemia in rats. Wardzala LJ; Hirshman M; Pofcher E; Horton ED; Mead PM; Cushman SW; Horton ES J Clin Invest; 1985 Aug; 76(2):460-9. PubMed ID: 3897286 [TBL] [Abstract][Full Text] [Related]
12. Effects of hypercalcemia, hypercalcemia and calcitonin on glucose stimulated insulin secretion in man. Ziegler R; Bellwinkel S; Schmidtchen D; Minne H Horm Metab Res; 1972 Jan; 4(1):60. PubMed ID: 4622099 [No Abstract] [Full Text] [Related]
13. A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat. Oakes ND; Kennedy CJ; Jenkins AB; Laybutt DR; Chisholm DJ; Kraegen EW Diabetes; 1994 Oct; 43(10):1203-10. PubMed ID: 7926289 [TBL] [Abstract][Full Text] [Related]
14. Serum insulin concentration, insulin release and degradation, glucose tolerance and in vivo insulin sensitivity in cholesterol-fed rats. Tsai AC J Nutr; 1977 Apr; 107(4):546-51. PubMed ID: 845692 [TBL] [Abstract][Full Text] [Related]
15. Normalization of insulin secretion by a selective alpha 2-adrenoceptor antagonist restores GLUT-4 glucose transporter expression in adipose tissue of type II diabetic rats. Angel I; Burcelin R; Prouteau M; Girard J; Langer SZ Endocrinology; 1996 May; 137(5):2022-7. PubMed ID: 8612543 [TBL] [Abstract][Full Text] [Related]
16. Skeletal muscle glycogenolysis is more sensitive to insulin than is glucose transport/phosphorylation. Relation to the insulin-mediated inhibition of hepatic glucose production. Rossetti L; Hu M J Clin Invest; 1993 Dec; 92(6):2963-74. PubMed ID: 8254050 [TBL] [Abstract][Full Text] [Related]
17. Diabetogenic effects of salmon calcitonin are attributable to amylin-like activity. Young AA; Wang MW; Gedulin B; Rink TJ; Pittner R; Beaumont K Metabolism; 1995 Dec; 44(12):1581-9. PubMed ID: 8786728 [TBL] [Abstract][Full Text] [Related]
18. Oral tungstate treatment improves only transiently alteration of glucose metabolism in a new rat model of type 2 diabetes. Fierabracci V; De Tata V; Pocai A; Novelli M; Barberà A; Masiello P Endocrine; 2002 Nov; 19(2):177-84. PubMed ID: 12588048 [TBL] [Abstract][Full Text] [Related]
19. The effects of anti-insulin serum on the disposal of an oral load of (6 14 C) glucose by the tissues of the rat. Moody AJ; Jeffcoate SL; Volund A Horm Metab Res; 1970 Jul; 2(4):193-9. PubMed ID: 5527946 [No Abstract] [Full Text] [Related]
20. Pharmacological studies on the hypoglycemic effect of 7,8-dihydro-2-(4-methylpiperazinyl)-4-(1-pyrrolidinyl)-6H-thi opyrano [3,2-d] pyrimidine dimaleate (MTP-1307), a novel hypoglycemic agent. Kunoh Y; Ogawa H; Nagasaka M; Asai H; Iguchi A; Niki A; Sakamoto N Arch Int Pharmacodyn Ther; 1989; 298():276-87. PubMed ID: 2667487 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]